Bladder cancer

L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Neoadjuvant therapy for pancreatic cancer

C Springfeld, CR Ferrone, MHG Katz… - Nature Reviews …, 2023 - nature.com
Patients with localized pancreatic ductal adenocarcinoma (PDAC) are best treated with
surgical resection of the primary tumour and systemic chemotherapy, which provides …

[HTML][HTML] Perioperative durvalumab for resectable non–small-cell lung cancer

JV Heymach, D Harpole, T Mitsudomi… - … England Journal of …, 2023 - Mass Medical Soc
Background Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients
with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine …

[PDF][PDF] 中国胃癌筛查与早诊早治指南(2022, 北京).

赫捷, 陈万青, 李兆申, 李霓, 任建松, 田金徽… - Chinese Journal of …, 2022 - dzrmyy.com
胃癌是中国常见的恶性肿瘤之一, 严重威胁居民生命健康. 胃癌高风险人群接受筛查和早诊,
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …

Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, J Chao… - Journal of the National …, 2022 - jnccn.org
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology

N Abu-Rustum, C Yashar, R Arend, E Barber… - Journal of the National …, 2023 - jnccn.org
Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …

[HTML][HTML] Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma

ND Gross, DM Miller, NI Khushalani… - … England Journal of …, 2022 - Mass Medical Soc
Background In a pilot study involving patients with cutaneous squamous-cell carcinoma, a
high percentage of patients had a pathological complete response with the use of two doses …

Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology

RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, D Cooke… - Journal of the National …, 2023 - jnccn.org
Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines

JJ Caudell, ML Gillison, E Maghami, S Spencer… - Journal of the National …, 2022 - jnccn.org
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …